- Home
- LPCN vs WATT Comparison
LPCN vs WATT Comparison
Compare LPCN & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- WATT
- Stock Information
- Founded
- LPCN 1997
- WATT 2012
- Country
- LPCN United States
- WATT United States
- Employees
- LPCN N/A
- WATT N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- WATT Radio And Television Broadcasting And Communications Equipment
- Sector
- LPCN Health Care
- WATT Technology
- Exchange
- LPCN Nasdaq
- WATT Nasdaq
- Market Cap
- LPCN 18.2M
- WATT 15.1M
- IPO Year
- LPCN N/A
- WATT 2014
- Fundamental
- Price
- LPCN $2.75
- WATT $8.36
- Analyst Decision
- LPCN Strong Buy
- WATT
- Analyst Count
- LPCN 1
- WATT 0
- Target Price
- LPCN $8.00
- WATT N/A
- AVG Volume (30 Days)
- LPCN 59.3K
- WATT 211.7K
- Earning Date
- LPCN 11-07-2025
- WATT 10-29-2025
- Dividend Yield
- LPCN N/A
- WATT N/A
- EPS Growth
- LPCN N/A
- WATT N/A
- EPS
- LPCN N/A
- WATT N/A
- Revenue
- LPCN $4,208,119.00
- WATT $1,976,000.00
- Revenue This Year
- LPCN N/A
- WATT $788.93
- Revenue Next Year
- LPCN N/A
- WATT $176.40
- P/E Ratio
- LPCN N/A
- WATT N/A
- Revenue Growth
- LPCN N/A
- WATT 434.05
- 52 Week Low
- LPCN $2.65
- WATT $3.67
- 52 Week High
- LPCN $6.17
- WATT $81.00
- Technical
- Relative Strength Index (RSI)
- LPCN 38.39
- WATT 51.68
- Support Level
- LPCN $2.75
- WATT $8.06
- Resistance Level
- LPCN $2.92
- WATT $8.82
- Average True Range (ATR)
- LPCN 0.14
- WATT 1.17
- MACD
- LPCN -0.04
- WATT -0.12
- Stochastic Oscillator
- LPCN 6.12
- WATT 17.03
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.